UsAgainstAlzheimer’s Applauds U.S. Senate for Passing Federal Funding Bill That Makes Significant Investments in the Fight to End Alzheimer’s

Bill Now Goes to President Biden for His Signature

Washington, DC (March 11, 2022) – In a tremendous victory for Alzheimer’s advocates, the United States Senate passed the 2022 Omnibus Appropriations bill, which makes robust investments in the effort to research, prevent, treat, and cure the sixth largest killer in the United States.George Vradenburg, chair and co-founder of UsAgainstAlzheimer’s released the following statement applauding this bipartisan victory:

“While our country is divided on many issues, one thing people of both political parties agree on is the need to end Alzheimer’s, and we saw that on full display on Wednesday in the House of Representatives and on Thursday in the Senate. UsAgainstAlzheimer’s is incredibly grateful to the bipartisan congressional leaders in both houses, including Senators Patty Murray and Roy Blunt, who have partnered with us to increase funding for research, create the Advanced Research Projects Agency for Health (ARPA-H), and better serve underrepresented communities. While we have a long fight ahead of us to cure this devastating disease, this bill is a major step in the right direction.”

For a more detailed description of the Alzheimer’s provisions in the funding bill, click here.

# # #

About UsAgainstAlzheimer’s

UsAgainstAlzheimer’s exists to conquer Alzheimer’s disease. We take on the toughest problems; bring all of “Us” together to break down barriers; advocate for research that will speed treatments to market; and drive changes that matter most to people living with the disease. We will not rest until brain-span equals lifespan - for everyone.